Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The main purpose of this study is to test the safety and tolerability and effectiveness of a new treatment, EMD 72000 (matuzumab), for advanced oesophagogastric cancer in combination with the chemotherapy regimen ECX (epirubicin, cisplatin and capecitabine). In addition the study will look at pharmacokinetic (how the the body takes up the drug) and pharmacodynamic parameters (what the drug does in the body).
Critère d'inclusion
- Esophageal Cancer,Gastric Cancer